Literature DB >> 18453591

The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptor.

Andrea Meiser1, Anja Mueller, Emma L Wise, Ellen M McDonagh, Sarah J Petit, Namita Saran, Peter C Clark, Timothy J Williams, James E Pease.   

Abstract

The chemokine receptor CXCR3 is expressed on the surface of both resting and activated T lymphocytes. We describe in this study the endocytosis of CXCR3 using T lymphocytes and CXCR3 transfectants. Chemokine-induced CXCR3 down-regulation occurred in a rapid, dose-dependent manner, with CXCL11 the most potent and efficacious ligand. Endocytosis was mediated in part by arrestins, but appeared to occur independently of clathrin and caveolae. In contrast to other chemokine receptors, which are largely recycled to the cell surface within an hour, cell surface replenishment of CXCR3 occurred over several hours and was dependent upon mRNA transcription, de novo protein synthesis, and transport through the endoplasmic reticulum and Golgi. Confocal microscopy and Western blotting confirmed the fate of endocytosed CXCR3 to be degradation, mediated in part by lysosomes and proteosomes. Site-directed mutagenesis of the CXCR3 C terminus revealed that internalization and degradation were independent of phosphorylation, ubiquitination, or a conserved LL motif. CXCR3 was found to be efficiently internalized in the absence of ligand, a process involving a YXXL motif at the extreme of the C terminus. Although freshly isolated T lymphocytes expressed moderate cell surface levels of CXCR3, they were only responsive to CXCL11 with CXCL9 and CXCL10 only having significant activity on activated T lymphocytes. Thus, the activities of CXCR3 are tightly controlled following mRNA translation. Because CXCR3(+) cells are themselves a source of IFN-gamma, which potently induces the expression of CXCR3 ligands, such tight regulation of CXCR3 may serve as a control to avoid the unnecessary amplification of activated T lymphocyte recruitment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18453591      PMCID: PMC2556381          DOI: 10.4049/jimmunol.180.10.6713

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  68 in total

1.  Expression pattern of CXCR3, CXCR4, and CCR3 chemokine receptors in the developing human brain.

Authors:  P Van Der Meer; S H Goldberg; K M Fung; L R Sharer; F González-Scarano; E Lavi
Journal:  J Neuropathol Exp Neurol       Date:  2001-01       Impact factor: 3.685

2.  Pathways for internalization and recycling of the chemokine receptor CCR5.

Authors:  Anja Mueller; Eamonn Kelly; Philip G Strange
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

3.  Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting.

Authors:  A Marchese; J L Benovic
Journal:  J Biol Chem       Date:  2001-12-07       Impact factor: 5.157

Review 4.  Regulated portals of entry into the cell.

Authors:  Sean D Conner; Sandra L Schmid
Journal:  Nature       Date:  2003-03-06       Impact factor: 49.962

5.  The carboxyl terminus of the chemokine receptor CCR3 contains distinct domains which regulate chemotactic signaling and receptor down-regulation in a ligand-dependent manner.

Authors:  Ian Sabroe; Annelies Jorritsma; Victoria E L Stubbs; Georgina Xanthou; Louise A Jopling; Paul D Ponath; Timothy J Williams; Philip M Murphy; James E Pease
Journal:  Eur J Immunol       Date:  2005-04       Impact factor: 5.532

6.  Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11.

Authors:  Michal Dagan-Berger; Rotem Feniger-Barish; Shani Avniel; Hanna Wald; Eithan Galun; Valentin Grabovsky; Ronen Alon; Arnon Nagler; Adit Ben-Baruch; Amnon Peled
Journal:  Blood       Date:  2005-12-20       Impact factor: 22.113

Review 7.  The caveolae membrane system.

Authors:  R G Anderson
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

8.  A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.

Authors:  I Sabroe; M J Peck; B J Van Keulen; A Jorritsma; G Simmons; P R Clapham; T J Williams; J E Pease
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

Review 9.  The ubiquitin-proteasome pathway and the regulation of growth hormone receptor availability.

Authors:  Ger J Strous; Peter van Kerkhof
Journal:  Mol Cell Endocrinol       Date:  2002-11-29       Impact factor: 4.102

10.  SOCS3 targets Siglec 7 for proteasomal degradation and blocks Siglec 7-mediated responses.

Authors:  Selinda J Orr; Nuala M Morgan; Richard J Buick; Caroline R Boyd; Joanne Elliott; James F Burrows; Caroline A Jefferies; Paul R Crocker; James A Johnston
Journal:  J Biol Chem       Date:  2006-11-30       Impact factor: 5.157

View more
  61 in total

Review 1.  Mechanisms regulating chemokine receptor activity.

Authors:  Laura D Bennett; James M Fox; Nathalie Signoret
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  Pancreatic stellate cells and CX3CR1: occurrence in normal pancreas and acute and chronic pancreatitis and effect of their activation by a CX3CR1 agonist.

Authors:  Masahiko Uchida; Tetsuhide Ito; Taichi Nakamura; Masayuki Hijioka; Hisato Igarashi; Takamasa Oono; Masaki Kato; Kazuhiko Nakamura; Koichi Suzuki; Ryoichi Takayanagi; Robert T Jensen
Journal:  Pancreas       Date:  2014-07       Impact factor: 3.327

Review 3.  Endocytic trafficking of chemokine receptors.

Authors:  Adriano Marchese
Journal:  Curr Opin Cell Biol       Date:  2013-12-14       Impact factor: 8.382

4.  Damage to the blood-brain barrier during experimental cerebral malaria results from synergistic effects of CD8+ T cells with different specificities.

Authors:  Chek Meng Poh; Shanshan W Howland; Gijsbert M Grotenbreg; Laurent Rénia
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 5.  CXCR3 in carcinoma progression.

Authors:  Bo Ma; Ahmad Khazali; Alan Wells
Journal:  Histol Histopathol       Date:  2015-02-09       Impact factor: 2.303

6.  Biased agonism as a mechanism for differential signaling by chemokine receptors.

Authors:  Sudarshan Rajagopal; Daniel L Bassoni; James J Campbell; Norma P Gerard; Craig Gerard; Tom S Wehrman
Journal:  J Biol Chem       Date:  2013-10-21       Impact factor: 5.157

7.  Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3.

Authors:  D J Scholten; M Canals; M Wijtmans; S de Munnik; P Nguyen; D Verzijl; I J P de Esch; H F Vischer; M J Smit; R Leurs
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

8.  T-bet promotes the accumulation of encephalitogenic Th17 cells in the CNS.

Authors:  Heather M Grifka-Walk; Benjamin M Segal
Journal:  J Neuroimmunol       Date:  2016-05-24       Impact factor: 3.478

9.  Rapid uptake and degradation of CXCL12 depend on CXCR7 carboxyl-terminal serine/threonine residues.

Authors:  Frauke Hoffmann; Wiebke Müller; Dagmar Schütz; Mark E Penfold; Yung H Wong; Stefan Schulz; Ralf Stumm
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

10.  Ubiquitination of chemokine receptors.

Authors:  Adriano Marchese
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.